The biotechnology market is well-positioned for robust growth, owing to increased investments in personalized medicine, numerous advancements in genetic engineering, regulatory support, and the pervasive adoption of AI in biopharmaceuticals.
Given the industry’s bright prospects, it could be wise to invest in fundamentally strong biotech stocks Alnylam Pharmaceuticals, Inc. (ALNY), Dynavax Technologies Corporation (DVAX), and Innoviva, Inc. (INVA) for solid gains.
